Sign inJoin waitlistJoin the waitlist

Lars Wagner

Chief, Division of Hematology/Oncology · Duke University Hospital

Credentials: · · · · ·

History

Division of Hematology/Oncology · Duke University Hospital
Present
Cincinnati Children's Hospital Medical Center
Present
Duke University Hospital
Present

Pediatric Hematology Oncology
St Jude Children's Research Hospital
1994–1997
Pediatrics
University of Tennessee College of Medicine
1991–1994
University of Kentucky College of Medicine
1987–1991

Research

Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma
Pediatric Blood & Cancer · 2007 · First of 7 authors · Corresponding · 146 citations
Treatment pathway of bone sarcoma in children, adolescents, and young adults
Review · Cancer · 2017 · 135 citations
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study
Journal of Clinical Oncology · 2011 · 129 citations

Maryam Fouladi
8 papers
MI
Michael Isakoff
7 papers
Roger Packer
6 papers
CF
Christine Fuller
5 papers · 1 as a fellow
DR
Damon Reed
5 papers
David Loeb
5 papers
HY
Hong Yin
5 papers
Masanori Hayashi
5 papers
Stewart Goldman
5 papers
Susan Blaney
5 papers
Brian Weiss
4 papers
John Maris
4 papers

Grants

Gene Transfer to Facilitate Dose-Intensification in the Treatment of Pediatric B*
National Cancer Institute · R21
Contact PI · $419.8K · Cincinnati Childrens Hosp Med Ctr
2006–2009

Clinical trials

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Principal investigator · Active not recruiting · Phase 1
Valent Technologies, LLC
2021–2026
Use of Propranolol to Reduce FDG Uptake in Brown Adipose Tissue in Pediatric Cancer Patients PET Scans
Principal investigator · Completed
Lars Wagner
2014–2016
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2012–2014
Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas
Principal investigator · Completed
Children's Hospital Medical Center, Cincinnati
2005–2012